Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Influence of the degree of donor bone marrow hyperplasia on patient clinical outcomes after allogeneic hematopoietic stem cell transplantation.

Tang F, Mo X, Zhang X, Wang Y, Yan C, Chen Y, Chen H, Han W, Chen Y, Wang F, Wang J, Sun Y, Zhang Y, Liu K, Huang X, Xu L.

Sci China Life Sci. 2019 Aug 13. doi: 10.1007/s11427-018-9509-y. [Epub ahead of print]

PMID:
31432375
2.

Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.

Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M.

Cochrane Database Syst Rev. 2014 Apr 20;(4):CD010189. doi: 10.1002/14651858.CD010189.pub2. Review.

PMID:
24748537
3.

Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.

Fan Q, Liu H, Liang X, Yang T, Fan Z, Huang F, Ling Y, Liao X, Xuan L, Xu N, Xu X, Ye J, Liu Q.

J Hematol Oncol. 2017 Jul 4;10(1):135. doi: 10.1186/s13045-017-0503-2.

4.

Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.

Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.

Klin Padiatr. 2005 May-Jun;217(3):135-41.

PMID:
15858704
5.

[HLA-10/10 matched unrelated donor versus sibling donor hematopoietic stem cell transplantation for adult acute myeloid leukemia].

Yao JF, Zhang GX, Shen YY, Zhang RL, He Y, Wei JL, Jiang EL, Yang DL, Feng SZ, Han MZ.

Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):460-466. doi: 10.3760/cma.j.issn.0253-2727.2019.06.003. Chinese.

PMID:
31340617
6.

[A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].

Zhou J, Fu YW, Liang LJ, Wang Q, Han LJ, Zu YL, Zhang Y, Zhu XH, Yu FK, Fang BJ, Wei XD, Song YP.

Zhonghua Nei Ke Za Zhi. 2016 Dec 1;55(12):927-931. doi: 10.3760/cma.j.issn.0578-1426.2016.12.004. Chinese.

PMID:
27916046
7.

[Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].

Chen X, Wei JL, Huang Y, He Y, Yang DL, Jiang EL, Ma QL, Zhou LK, Lin XT, Shen YY, Feng SZ, Han MZ.

Zhonghua Xue Ye Xue Za Zhi. 2012 Aug;33(8):610-4. Chinese.

PMID:
23134851
8.
9.

[Increased risk of severe acute graft-versus-host disease in low body mass index patients undergoing haploidentical allogeneic stem cell transplantation].

Chen Y, Xu L, Liu D, Liu K, Chen H, Zhang X, Wang F, Wang J, Wang Y, Han W, Chen Y, Yan C, Zhao T, Huang X.

Zhonghua Nei Ke Za Zhi. 2014 Sep;53(9):710-4. Chinese.

PMID:
25511404
10.

[Efficacy comparison between Ph⁺ ALL patients treated with chemotherapyplus tyrosine kinase inhibitors followed by allo-HSCT and Ph-ALL patients with allo-HSCT: a case control study from a single center].

Hu J, Wang L, Li Y, Qiu Z, Xu W, Sun Y, Yin Y, Liu W, Ou J, Wang M, Wang W, Liang Z, Cen X, Ren H.

Zhonghua Xue Ye Xue Za Zhi. 2015 Jul;36(7):593-7. doi: 10.3760/cma.j.issn.0253-2727.2015.07.014. Chinese.

PMID:
26304085
11.

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.

Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T.

Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.

12.

Double haploidentical hematopoietic stem cell transplantation results in successful engraftment of bone marrow from both donors without graft-versus-host or graft-versus-graft effects.

Biswas CS, Sauter CT, Bailey CP, Rittenberg D, Luo X, Panis MM, Budak-Alpdogan T, Grosso D, Flomenberg N, Alpdogan O.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1808-18. doi: 10.1016/j.bbmt.2012.09.012. Epub 2012 Oct 16.

13.

Enumeration of bone marrow plasmacytoid dendritic cells by multiparameter flow cytometry as a prognostic marker following allogeneic hematopoietic stem cell transplantation.

Su RJ, Green R, Chen M.

Blood Cells Mol Dis. 2018 Mar;69:107-112. doi: 10.1016/j.bcmd.2017.10.004. Epub 2017 Oct 31.

PMID:
29137845
14.

Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.

Le Bourgeois A, Mohr C, Guillaume T, Delaunay J, Malard F, Loirat M, Peterlin P, Blin N, Dubruille V, Mahe B, Gastinne T, Le Gouill S, Moreau P, Mohty M, Planche L, Lode L, Bene MC, Chevallier P.

Biol Blood Marrow Transplant. 2013 Jun;19(6):934-9. doi: 10.1016/j.bbmt.2013.03.009. Epub 2013 Mar 21.

15.
16.

Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies.

Baker M, Wang H, Rowley SD, Cai L, Pecora AL, Skarbnik A, Vesole DH, Adler-Brecher B, Kim D, Donato ML.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2047-2055. doi: 10.1016/j.bbmt.2016.08.003. Epub 2016 Aug 10.

17.

[Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].

Liu W, Li Y, Qiu ZX, Yin Y, Sun YH, Xu WL, Wang Q, Liang ZY, Dong YJ, Wang LH, Cen QN, Wang MJ, Wang WS, Ou JP, Ren HY.

Zhonghua Nei Ke Za Zhi. 2018 Aug 1;57(8):576-581. doi: 10.3760/cma.j.issn.0578-1426.2018.08.008. Chinese.

PMID:
30060329
18.

Reduced BUCY 2 and G-CSF-primed bone marrow associates with low graft-versus-host-disease and transplant-related mortality in allogeneic HSCT.

Leon Rodriguez E, Rivera Franco MM, Perez Alvarez SI.

Ann Hematol. 2017 Sep;96(9):1525-1531. doi: 10.1007/s00277-017-3056-0. Epub 2017 Jul 9.

PMID:
28691152
19.

Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Nagler A, Labopin M, Shimoni A, Niederwieser D, Mufti GJ, Zander AR, Arnold R, Greinix H, Cornelissen JJ, Jackson GH, Craddock C, Bunjes DW, Ganser A, Russell NH, Kyrcz-Krzemien S, Rocha V, Mohty M.

Biol Blood Marrow Transplant. 2012 Sep;18(9):1422-9. doi: 10.1016/j.bbmt.2012.02.013. Epub 2012 Mar 20.

Supplemental Content

Support Center